Quantcast

Latest bladder cancer Stories

2014-04-12 23:01:34

A Louisiana jury’s decision to award $9 billion in damages to a man who says his bladder cancer was caused by the drug Actos could pave a new legal path for other bladder cancer patients. Raleigh, NC (PRWEB) April 12, 2014 Bladder cancer patients who took the drug Actos to control diabetes may now be able to establish a legal nexus or connection between the drug and the disease, thanks to a high-profile legal decision made this week.* If you are a bladder cancer patient who took Actos,...

2014-04-12 23:01:18

The Firm is evaluating Actos lawsuits on behalf of individuals who allegedly developed bladder cancer due to long-term use of Actos. New York, New York (PRWEB) April 12, 2014 Actos lawsuits (http://www.theactoslawsuitcenter.com/) alleging that long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in federal and state courts throughout the country, Bernstein Liebhard LLP reports. According to court documents, the Nevada Circuit Court...

2014-04-11 08:24:36

SAN DIEGO, April 11, 2014 /PRNewswire/ -- GenomeDx Biosciences announced today that two study abstracts for the company's genomic tests for prostate and bladder cancers have been selected as "Best Posters in a Poster Session" by conference organizers at the 29(th) Annual European Association of Urology Congress. The first poster presentation demonstrates the clinical validation of the Decipher® prostate cancer classifier for predicting treatment failure in men treated with...

2014-04-09 23:25:06

Biochemical testing suggests a pair of proteins can find and monitor bladder cancer better than standard techniques. Raleigh, NC (PRWEB) April 09, 2014 A team of Egyptian biochemists say angiogenin and clusterin – two proteins vital to certain cellular processes – could make bladder cancer diagnosis more accurate and treatments more effective. Click here to read details on the study which has just been posted on the Cancer Monthly website. Researchers with the Faculty of...

2014-04-08 23:02:42

The Firm is filing Actos lawsuits on behalf of individuals who took Actos for an extended period of time and allegedly developed bladder cancer due to their use of the Type 2 diabetes medication. New York, NY (PRWEB) April 08, 2014 The first federal trial of an Actos bladder cancer lawsuit (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) has ended in a significant victory for the Plaintiff, Bernstein Liebhard LLP reports. According to court documents, the jury hearing the...

2014-04-08 23:01:24

Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. were ordered to pay a total of $9 billion in punitive damages for allegedly withholding information about the potential risks associated with the diabetes drug Actos. Flood Law Group says it agrees with the decision and is available to investigate potential Actos bladder cancer lawsuits. Washington, D.C. (PRWEB) April 08, 2014 A U.S. jury ordered Takeda Pharmaceuticals and marketing partner Eli Lilly & Co. to pay a total...

2014-04-08 23:00:54

Takeda Pharmaceutical Co. and Eli Lilly & Co. must pay a total of $9 billion in punitive damages after they were found to have concealed diabetes drug, Actos’, cancer risks. Parker Waichman LLP continues to evaluate cases of bladder cancer in patients who allege serious injuries associated with Actos. New York, New York (PRWEB) April 08, 2014 Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective drugs and medical devices, reports...

2014-04-07 12:50:07

A University of Colorado Cancer Center study published today in Journal of the National Cancer Institute (with related research being presented this weekend at the American Association for Cancer Research Annual Conference 2014) details the discovery of a new genetic driver of bladder cancer: silencing of the gene AGL. "We tend to think of cancer resulting from mutations that let genes make things they shouldn't or turn on when they should be quiet. But cancer can also result from loss of...

2014-04-07 08:31:12

New Pre-Clinical Data Presented at AACR Annual Meeting in San Diego SAN DIEGO, April 7, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced the presentation of new pre-clinical data showing the ability of its lead drug candidate Pracinostat to inhibit bladder cancer cell growth and induce activated transcription factor 3 (ATF-3) expression, a potential marker of tumor response. The data...

2014-04-04 23:22:41

Researchers in Italy say their review of studies on the link between selenium and malignancies like bladder cancer turned up too little evidence to support supplementation. Raleigh, NC (PRWEB) April 04, 2014 Italian scientists say patients fighting bladder cancer and other types of cancer are not likely to get any benefit from the metalloid nutritional supplement, selenium. The new meta-analysis has just been posted on the Cancer Monthly website and can be read by clicking here....


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related